Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Long-term follow-up and treatment of congenital alveolar proteinosis
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Long-term follow-up and treatment of congenital alveolar proteinosis
Creator
Schaub, Bianca
Griese, Matthias
Reiter, Karl
Nicolai, Thomas
Brasch, Frank
Glöckner-Pagel, Judith
Hector, Andreas
Lohse, Peter
Lohse, Pia
Muensterer, Oliver
Pamir, Asli
Ripper, Jan
Schams, Andrea
Schön, Carola
Sibbersen, Anke
Source
PMC
abstract
BACKGROUND: Clinical presentation, diagnosis, management and outcome of molecularly defined congenital pulmonary alveolar proteinosis (PAP) due to mutations in the GM-CSF receptor are not well known. CASE PRESENTATION: A 2 1/2 years old girl was diagnosed as having alveolar proteinosis. Whole lung lavages were performed with a new catheter balloon technique, feasible in small sized airways. Because of some interstitial inflammation in the lung biopsy and to further improve the condition, empirical therapy with systemic steroids and azathioprin, and inhaled and subcutaneous GMCSF, were used. Based on clinical measures, total protein and lipid recovered by whole lung lavages, all these treatments were without benefit. Conversely, severe respiratory viral infections and an invasive aspergillosis with aspergilloma formation occurred. Recently the novel homozygous stop mutation p.Ser25X of the GMCSF receptor alpha chain was identified in the patient. This mutation leads to a lack of functional GMCSF receptor and a reduced response to GMCSF stimulation of CD11b expression of mononuclear cells of the patient. Subsequently a very intense treatment with monthly lavages was initiated, resulting for the first time in complete resolution of partial respiratory insufficiency and a significant improvement of the overall somato-psychosocial condition of the child. CONCLUSIONS: The long term management from early childhood into young adolescence of severe alveolar proteinosis due to GMCSF receptor deficiency requires a dedicated specialized team to perform technically demanding whole lung lavages and cope with complications.
has issue date
2011-08-17
(
xsd:dateTime
)
bibo:doi
10.1186/1471-2431-11-72
bibo:pmid
21849033
has license
cc-by
sha1sum (hex)
8be183b59a7ccf2598c301d4c465f559d11ad80a
schema:url
https://doi.org/10.1186/1471-2431-11-72
resource representing a document's title
Long-term follow-up and treatment of congenital alveolar proteinosis
has PubMed Central identifier
PMC3175167
has PubMed identifier
21849033
schema:publication
BMC Pediatr
resource representing a document's body
covid:8be183b59a7ccf2598c301d4c465f559d11ad80a#body_text
is
schema:about
of
named entity 'Clinical presentation'
named entity 'GM-CSF receptor'
named entity 'Long-term'
named entity 'alveolar proteinosis'
named entity 'congenital'
named entity 'alveolar proteinosis'
named entity '3 living'
named entity 'alveolar proteinosis'
named entity 'Pneumocystis'
named entity 'lung lavage'
named entity 'alveolar proteinosis'
named entity 'neutrophils'
named entity 'receptor'
named entity 'recombinant'
named entity 'respiratory insufficiency'
named entity 'protein'
named entity 'nutrition'
named entity '1, 2'
named entity 'immunosuppression'
named entity 'surgical resection'
named entity 'alveolar macrophages'
named entity 'growth failure'
named entity 'GM-CSF receptor'
named entity 'rare diseases'
named entity 'signal transduction'
named entity 'x400'
named entity 'GM-CSF receptor'
named entity 'cytospin'
named entity 'Lactate dehydrogenase'
named entity 'rare condition'
named entity 'lavage'
named entity 'WLL'
named entity 'syringe'
named entity 'ARDS'
named entity 'GM-CSF'
named entity 'histology'
named entity 'Macroscopic'
named entity 'endotracheal tube'
named entity 'PAP'
named entity 'PAP'
named entity 'protein'
named entity 'auto-immune'
named entity 'congenital'
named entity 'infection'
named entity 'IgG1'
named entity 'alveolar'
named entity 'congenital'
named entity 'CD11b'
named entity 'total protein'
named entity 'long term'
named entity 'congenital'
named entity 'CD11b'
named entity 'subcutaneously'
named entity 'GM-CSF receptor'
named entity 'CD11b'
named entity 'microscopy'
named entity 'WLL'
named entity 'total protein'
named entity 'Niemann Pick disease'
named entity 'GM-CSF'
named entity 'left lung'
named entity 'age 12'
named entity 'WLL'
named entity 'body temperature'
named entity 'CD11b'
named entity 'GM-CSF'
named entity 'left lung'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software